Key facts
- It has raised $5.0M; the latest was Seed Round ($5.0M) in Jan 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for BlueMedix
- ·The full record, as it builds
Funding rounds
No funding rounds for BlueMedix are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BlueMedix
Operator of an online and physical pharmacy intended to provide access to genuine and affordable medicines and healthcare products. The company's platform offers a wide range of pharmaceuticals, wellness products, vitamins, diabetic care kits and other health-related items, ensuring convenience and accessibility through online ordering, reliable delivery and a commitment to offering prescribed medicines, enabling patients to manage chronic conditions and health needs while reducing out-of-pocket costs and medication shortages.
- Sector
- Information Technology
- HQ
- Bangalore, India
- Founded
- 2017
- Website
- bluemedix.in/
- Ownership
- Privately Held (backing)
BlueMedix doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BlueMedix shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BlueMedix in its N-PORT filings yet. We sweep new filings monthly.